Tomas Kiselak is a Managing Member at Fairmount Funds Management LLC, a healthcare investment firm he co-founded in April 2016. Prior to Fairmount, Mr. Kiselak was a managing director at RA Capital Management, LLC.
Mr. Kiselak serves as the chairman of the board of directors of Viridian Therapeutics, Inc. and is a director for Apogee Therapeutics, Inc., Dianthus Therapeutics, Inc., and several private companies. He received his B.S. neuroscience and economics from Amherst College.